Delivery Order SPE2DB22D2103-SPE2DB24FR8XW

Award Date 2/20/24
Potential Completion Date 3/12/24
Potential Value $2.9K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide VARIVAX vaccine with diluents. The contract has a potential value of $8,603.73 and a completion date of March 12, 2024. Amerisourcebergen Drug Corp is the prime contractor for this delivery order, which is not associated with any set-aside program. Additionally, Amerisourcebergen Drug Corp holds an indefinite delivery...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide VARIVAX vaccine with diluents. The contract has a potential value of $1,898.74 and a completion date of March 5, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00 through December 31,...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of VARIVAX vaccine with diluents. The contract has a potential value of $3,797.48 and a completion date of February 23, 2024. Amerisourcebergen Drug Corp is the prime contractor and there are no set-aside designations associated with this contract. The company has received numerous federal contract awards from DLA...
The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide VARIVAX vaccine with diluents. The contract is a firm fixed price award with a ceiling value of $1,911.94 and a performance period through April 3, 2024. AmerisourceBergen Drug Corp is the prime contractor for this delivery order, which is part of a larger indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00...
The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of VARIVAX vaccine with diluents. The contract has a potential value of $3,797.48 and a completion date of March 5, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor and will be delivering the pharmaceutical products to DLA Troop Support Medical facilities in support of...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of VARIVAX vaccine with diluents. The contract has a potential value of $3,823.88 and a performance period through March 21, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 awarded by DLA to...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide VARIVAX vaccines with diluents. The contract has a potential value of $2,848.11 and a completion date of February 27, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. This delivery order is likely part of a larger indefinite delivery contract (IDC) valued up to...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply the VARIVAX vaccine with diluents. The contract has a potential value of $4,746.85 and a completion date of February 29, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. Amerisourcebergen Drug Corp holds an indefinite delivery contract with DLA, valued up to...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide VARIVAX vaccine with diluents. The contract has a potential value of $76,477.60 and a period of performance through March 13, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation. This order is issued under a larger indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00,...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $3,823.88 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of VARIVAX vaccine with diluents. Amerisourcebergen Drug Corp is the prime contractor on this contract, which has a period of performance through March 12, 2024. This contract is not associated with any set-aside designation. Amerisourcebergen Drug Corp also holds an indefinite delivery contract with...
  • SPE2DB22D2103
    Indefinite Delivery Contract
  • SPE2DB22D2103-SPE2DB24FR8XW
    Delivery Order

The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide VARIVAX vaccine with diluents. The contract has a potential value of $2,867.91 and a completion date of March 12, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order contract, which is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that the company holds with DLA to provide pharmaceutical products and medical supplies to military treatment facilities worldwide. This contract does not have a set-aside designation.

Generated 5/21/24, 10:34 AM